NEWS SOURCE: Optimal Therapeutics
CEDAR GROVE, NJ /Send2Press Newswire/ — Optimal Therapeutics announces the signing of a licensing agreement with Kwowa Hakko USA for the ingredient Cognizin(R) to be included in their brain function formula Neurovar.
Optimal Therapeutics company spokesperson Camille Westhoff states “Cognizin(R) is an exciting ingredient that immediately places the Neurovar formulation at the top in this competitive class.”
Neurovar also contains other quality ingredients like Phosphatidyl Serine, Bacopa Monniera, Alpha GPC, Ginkgo Biloba, Vinpocetine and Acetyl-L-Carnitine.
Optimal Therapeutics, a Neutraceutical manufacturer based in New Jersey, also produces Zyroxin, Zalestra, Phosoplex, Fematril, Viastat amongst other quality formulations. Optimal Therapeutics products can be found online at www.BodEStore.com and at Amazon.
News issued by: Optimal Therapeutics
# # #
Original Story ID: (190) :: 2005-03-0321-005
Original Keywords: Neutraceutical manufacturer, Nutraceuticals, Camille Westhoff, Cognizin, Kwowa Hakko USA, Neurovar, vitamins, nutrition, health newswire, news Optimal Therapeutics
NEWS SOURCE: Optimal Therapeutics | Published: 2005-03-21 20:25:00
IMPORTANT NOTICE FOR ARCHIVAL CONTENT ABOVE: The above archival press release content was issued on behalf of the noted "news source" who provided the content (text and image[s]) and is solely responsible for its accuracy. Links may not work if very old; use such with caution. Send2Press does not represent the "news source" in any capacity. For questions about this content contact the company/person mentioned directly. To report fraud or illegal material, or DMCA complaints, please contact Send2Press via our main site (any such complaints must be made in writing, not by phone).
